Predictions
BioNTech SE ADR
Start price
Target price
Perf. (%)
€90.00
09.11.20
09.11.20
€180.00
09.11.21
09.11.21
103.67%
04.05.21
04.05.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very Future proof/growth oriented business model
Capable Management
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€34.41
09.11.20
09.11.20
€40.00
09.11.21
09.11.21
18.27%
02.11.21
02.11.21
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
AT&S Austria Technologie & Systemtechnik AG
Start price
Target price
Perf. (%)
€18.34
08.11.20
08.11.20
-
0.55%
14.11.20
14.11.20
BE Semiconductor Industries N.V.
Start price
Target price
Perf. (%)
€39.30
08.11.20
08.11.20
€45.00
-0.15%
14.11.20
14.11.20
Could be worthwhile Investment >10% per year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.15
08.11.20
08.11.20
€5.00
08.11.21
08.11.21
-29.28%
09.11.21
09.11.21
Could be worthwhile Investment >10% per year
Nemetschek SE
Start price
Target price
Perf. (%)
€67.20
07.11.20
07.11.20
€72.00
07.11.21
07.11.21
3.78%
21.07.21
21.07.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
High valuation
Qorvo Inc.
Start price
Target price
Perf. (%)
€126.00
07.11.20
07.11.20
-
07.11.21
07.11.21
18.25%
24.03.21
24.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Some uniques
Growths slower than the competition
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.30
07.11.20
07.11.20
-
07.11.21
07.11.21
15.65%
15.07.21
15.07.21
Probably not worthwhile Investment
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€5.80
07.11.20
07.11.20
-
07.11.21
07.11.21
-0.34%
15.07.21
15.07.21
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€5.20
07.11.20
07.11.20
€6.40
23.49%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
Sealed Air Corp.
Start price
Target price
Perf. (%)
€36.00
06.11.20
06.11.20
-
06.11.21
06.11.21
-1.67%
28.01.21
28.01.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Increased challenges to pay loans and raise capital
Low dividend yield expected
Washington Prime Group Inc.
Start price
Target price
Perf. (%)
€4.22
06.11.20
06.11.20
€2.70
06.11.21
06.11.21
91.79%
13.12.20
13.12.20
Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
NVIDIA Corp.
Start price
Target price
Perf. (%)
€3.04
06.11.20
06.11.20
-
06.11.21
06.11.21
-12.90%
17.01.21
17.01.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Small challenges to pay loans and raise capital
ROE higher than 15% per year
Ferrari NV
Start price
Target price
Perf. (%)
€176.05
06.11.20
06.11.20
€180.00
2.13%
18.11.20
18.11.20
Revenue growth > 30% per year expected
Undervalued
Very Future proof/growth oriented business model
Well known brand
Urban One Inc.
Start price
Target price
Perf. (%)
€5.05
06.11.20
06.11.20
€7.00
-20.00%
16.11.20
16.11.20
Risky Investment
Urban One Inc.
Start price
Target price
Perf. (%)
€5.05
06.11.20
06.11.20
€9.00
06.11.21
06.11.21
-20.00%
14.11.20
14.11.20
EBIT decline > 20% expected
very negative Cash Flow expected
Junk rating
High challenges to pay loans and raise capital
Compagnie Financière Richemont SA ADR
Start price
Target price
Perf. (%)
€6.50
06.11.20
06.11.20
€6.00
2.97%
10.11.20
10.11.20
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
NIO Inc. ADR
Start price
Target price
Perf. (%)
€37.30
06.11.20
06.11.20
€40.00
7.51%
12.11.20
12.11.20
Innovative
EBIT growth >5% per year expected
Top 10 in its market
Known brand
Farfetch Ltd
Start price
Target price
Perf. (%)
€35.80
06.11.20
06.11.20
€40.00
5.03%
11.11.20
11.11.20
Top 10 in its market
Known brand
Probably not worthwhile Investment
Low dividend yield expected
Ose Pharma International S.A.
Start price
Target price
Perf. (%)
€9.36
06.11.20
06.11.20
€14.00
06.11.21
06.11.21
23.50%
21.09.21
21.09.21
Could be worthwhile Investment >10% per year